Aberrant DNA methylation associated with the development of metabolic dysfunction-associated fatty liver disease DOI Creative Commons
А.Е. Абатуров, Anna Nikulina, О.О. Русакова

и другие.

CHILD`S HEALTH, Год журнала: 2024, Номер 19(4), С. 230 - 242

Опубликована: Июль 28, 2024

The literature review deals with DNA methylation, a key epigenetic mechanism that controls the activity of gene transcription, plays decisive role in formation genomic imprinting, silencing, X-chromosome inactivation, RNA splicing, repair, cell differentiation and reprogramming, also determines occurrence development liver steatotic lesions metabolic disorders. Methylation cytosine dinucleotide (CpG) can be represented two types: de novo CpG which is carried out by 5mC writers — DNA-(cytosine-5)-methyltransferase (DNMT) 3a 3b, suppor­ting performed DNMT1 during replication. It has been found maintenance methylation allows preservation pattern characteristic progenitor cells new generation, body associated its increased expression. Active demethylation TET dioxygenases, including three enzymatic representatives: TET1, TET2 TET3. demonstrated aberrant nucleotides directly related to lipid synthesis, degree oxidative stress, steatosis, low-grade inflammation, insulin resistance, progression fibrosis. authors presented detail functions features methyltransferases, erasers, readers sites; possible violations balance erasers DNA; landscape patterns; clinical significance signatures dysfunction-associated fatty disease. Global hypomethylation genome, at least 55 genes, observed patients emphasize use promising direction for early diagnosis prognosis course disease, while study molecular components mechanisms involved regulation expression, dependence their on exposure exposome will allow persona­lize improve recommendations lifestyle diet modification

Язык: Английский

Cardiac Fibroblastic Niches in Homeostasis and Inflammation DOI
Nadine Cadosch, Cristina Gil‐Cruz, Christian Perez‐Shibayama

и другие.

Circulation Research, Год журнала: 2024, Номер 134(12), С. 1703 - 1717

Опубликована: Июнь 6, 2024

Fibroblasts are essential for building and maintaining the structural integrity of all organs. Moreover, fibroblasts can acquire an inflammatory phenotype to accommodate immune cells in specific niches provide migration, differentiation, growth factors. In heart, balancing fibroblast activity is critical cardiac homeostasis optimal organ function during inflammation. sustain by generating local niche environments that support housekeeping functions actively engaging intercellular cross talk. During perturbations, rapidly switch state communicate with infiltrating orchestrate cell migration activity. Here, we summarize current knowledge on molecular landscape fibroblasts, focusing their dual role promoting tissue modulating cell–cardiomyocyte interaction. addition, discuss potential future avenues manipulating myocardial

Язык: Английский

Процитировано

7

The Role of Extracellular Vesicles in the Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease and Other Liver Diseases DOI Open Access
Elena Grossini, Mohammad Mostafa Ola Pour, Sakthipriyan Venkatesan

и другие.

International Journal of Molecular Sciences, Год журнала: 2025, Номер 26(11), С. 5033 - 5033

Опубликована: Май 23, 2025

The increasing prevalence of liver diseases, such as metabolic dysfunction-associated steatotic disease (MASLD), presents considerable medical challenges, particularly given the absence approved pharmacological treatments, which underscores necessity to comprehend its underlying mechanisms. Extracellular vesicles (EVs), are tiny particles released by cells, play a crucial role in facilitating communication and can transport harmful molecules that promote inflammation tissue damage. These EVs involved progression various types disorders since they aggravate oxidative stress. Because their critical role, it is believed widely initiation MASLD, well viral hepatitis, alcoholic disease, drug-induced injury, hepatocellular carcinoma. This review emphasizes recent findings regarding functions above pathologies potential new therapeutic targets, paving way for innovative approaches address those detrimental conditions.

Язык: Английский

Процитировано

0

Impact of genetic background as a risk factor for atherosclerotic cardiovascular disease: A protocol for a nationwide genetic case-control (CV-GENES) study in Brazil DOI Creative Commons
Haliton Alves de Oliveira, Precil Diego Miranda de Menezes Neves, Gustavo Bernardes de Figueiredo Oliveira

и другие.

PLoS ONE, Год журнала: 2024, Номер 19(3), С. e0289439 - e0289439

Опубликована: Март 13, 2024

Atherosclerotic Cardiovascular Disease (ASCVD) represents the leading cause of death worldwide, and individual screening should be based on behavioral, metabolic, genetic profile derived from data collected in large population-based studies. Due to polygenic nature ASCVD, we aimed assess association genomics with ASCVD risk its impact occurrence acute myocardial infarction, stroke, or peripheral artery thrombotic-ischemic events at population level. CardioVascular Genes (CV-GENES) is a nationwide, multicenter, 1:1 case-control study 3,734 patients Brazil. Inclusion criterion for cases first one events. Individuals without known will eligible as controls. A core lab perform analyses through low-pass whole genome sequencing exome sequencing. In order estimate independent between polymorphisms score (PRS) built hybrid approach including effect size each Single Nucleotide Polymorphism (SNP), number alleles observed, sample ploidy, total SNPs included PRS, non-missing sample. addition, presence pathogenic likely variants screened 8 genes ( ABCG5 , ABCG8 APOB APOE LDLR LDLRAP1 LIPA PCSK9 ) associated atherosclerosis. Multiple logistic regression applied adjusted odds ratios (OR) 95% confidence intervals (CI), attributable risks calculated. Clinical trial registration: This registered clinicaltrials.gov NCT05515653 ).

Язык: Английский

Процитировано

2

Aberrant DNA methylation associated with the development of metabolic dysfunction-associated fatty liver disease DOI Creative Commons
А.Е. Абатуров, Anna Nikulina, О.О. Русакова

и другие.

CHILD`S HEALTH, Год журнала: 2024, Номер 19(4), С. 230 - 242

Опубликована: Июль 28, 2024

The literature review deals with DNA methylation, a key epigenetic mechanism that controls the activity of gene transcription, plays decisive role in formation genomic imprinting, silencing, X-chromosome inactivation, RNA splicing, repair, cell differentiation and reprogramming, also determines occurrence development liver steatotic lesions metabolic disorders. Methylation cytosine dinucleotide (CpG) can be represented two types: de novo CpG which is carried out by 5mC writers — DNA-(cytosine-5)-methyltransferase (DNMT) 3a 3b, suppor­ting performed DNMT1 during replication. It has been found maintenance methylation allows preservation pattern characteristic progenitor cells new generation, body associated its increased expression. Active demethylation TET dioxygenases, including three enzymatic representatives: TET1, TET2 TET3. demonstrated aberrant nucleotides directly related to lipid synthesis, degree oxidative stress, steatosis, low-grade inflammation, insulin resistance, progression fibrosis. authors presented detail functions features methyltransferases, erasers, readers sites; possible violations balance erasers DNA; landscape patterns; clinical significance signatures dysfunction-associated fatty disease. Global hypomethylation genome, at least 55 genes, observed patients emphasize use promising direction for early diagnosis prognosis course disease, while study molecular components mechanisms involved regulation expression, dependence their on exposure exposome will allow persona­lize improve recommendations lifestyle diet modification

Язык: Английский

Процитировано

0